Keyphrases
Schizophrenia
100%
Therapeutic Target
100%
Nicotinic Acetylcholine Receptor (nAChR)
100%
Procognitive
50%
Clinical Application
33%
Cognitive Impairment
33%
Negative Symptoms
33%
Positive Symptoms
33%
Cognitive Agents
33%
Cognitive Effects
16%
Effective Treatment
16%
Functional Outcome
16%
Receptor Antagonist
16%
Antipsychotics
16%
Psychiatry
16%
Genetic Evidence
16%
Hallucinations
16%
Clinical Trial Design
16%
Schizophrenic Patients
16%
Cognitive Dysfunction
16%
Dose-response Relationship
16%
Positive Allosteric Modulator
16%
Intermittent Dosing
16%
Polypharmacy
16%
Mental Illness
16%
Delusions
16%
Anhedonia
16%
Confounding Effect
16%
Social Withdrawal
16%
Pharmacologic Strategies
16%
Challenging Issues
16%
Design Requirements
16%
Translational Value
16%
Cognitive Strategies
16%
Behavioral Evidence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
100%
Nicotinic Receptor
100%
Cognitive Defect
60%
Positive Syndrome
40%
Negative Syndrome
40%
Symptom
20%
Clinical Trial Design
20%
Receptor Antagonist
20%
Typical Antipsychotic
20%
Positive Allosteric Modulator
20%
Hallucination
20%
Polypharmacy
20%